Literature DB >> 8349604

Polyamine-like actions of peptides derived from conantokin-G, an N-methyl-D-aspartate (NMDA) antagonist.

P Chandler1, M Pennington, M L Maccecchini, N T Nashed, P Skolnick.   

Abstract

Conantokins-T and -G are highly conserved polypeptides derived from Conus venoms. The N-methyl-D-aspartate (NMDA) antagonist properties of these compounds have been attributed to a potent noncompetitive inhibition of polyamine responses. Substitution of the highly conserved gamma-carboxyglutamate residues as well as modification of the N and C termini of conantokin-G abolished the inhibition of polyamine responses at the NMDA receptor complex. However, several of these modified polypeptides closely mimicked the neurochemical profile of polyamines at the NMDA receptor complex. One of these derivatives, Tyr0-conantokin-G, was found to be the most potent compound exhibiting polyamine-like actions at the NMDA receptor complex described to date, approximately 7-fold more potent than spermine. Circular dichroism studies demonstrate a significant alpha-helical content in conantokin-G (27% in aqueous medium). However, this alpha-helicity is not sufficient for the NMDA antagonist action of the parent peptide and is neither necessary nor sufficient for the polyamine-like behavior of several conantokin-G analogs. The modified conantokin-G derivatives described in this report should be useful probes for examining the role of both polyamines and the polyamine recognition site in the operation of the NMDA receptor complex.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8349604

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Non-strict strand orientation of the Ca2+-induced dimerization of a conantokin peptide variant with sequence-shifted gamma-carboxyglutamate residues.

Authors:  Qiuyun Dai; Cai Xiao; Mingxin Dong; Zhuguo Liu; Zhenyu Sheng; Francis J Castellino; Mary Prorok
Journal:  Peptides       Date:  2009-01-24       Impact factor: 3.750

2.  From molecular phylogeny towards differentiating pharmacology for NMDA receptor subtypes.

Authors:  Randall J Platt; Kigen J Curtice; Vernon D Twede; Maren Watkins; Paweł Gruszczyński; Grzegorz Bulaj; Martin P Horvath; Baldomero M Olivera
Journal:  Toxicon       Date:  2014-02-07       Impact factor: 3.033

Review 3.  The role of group I metabotropic glutamate receptors in neuronal excitotoxicity in Alzheimer's disease.

Authors:  Vicky W-W Tsai; Heather L Scott; Richard J Lewis; Peter R Dodd
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

4.  Metal-ion-binding properties of synthetic conantokin-G.

Authors:  T Blandl; J Zajicek; M Prorok; F J Castellino
Journal:  Biochem J       Date:  1997-12-15       Impact factor: 3.857

Review 5.  Neuroprotective and cardioprotective conopeptides: an emerging class of drug leads.

Authors:  Vernon D Twede; George Miljanich; Baldomero M Olivera; Grzegorz Bulaj
Journal:  Curr Opin Drug Discov Devel       Date:  2009-03

6.  Antagonistic action on NMDA/GluN2B mediated currents of two peptides that were conantokin-G structure-based designed.

Authors:  Edwin A Reyes-Guzman; Nohora Vega-Castro; Edgar A Reyes-Montaño; Esperanza Recio-Pinto
Journal:  BMC Neurosci       Date:  2017-05-16       Impact factor: 3.288

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.